Insulin-like growth factor family and combined antisense approach in therapy of lung carcinoma

Molecular Medicine

Volumn 8, Issue 3, 2002, Pages 149-157

  Pavelić, Jasminka ^a   Pavelić, Ljubomir ^a   Karadža, Jerolim ^a   Križanac, Šimun ^a   Unešić, Josip ^a   Spaventi, Šime ^a   Pavelić, Krešimir ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IGF GENE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCATCHARD PLOT; WESTERN BLOTTING;

EID: 0036046238     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402007     Document Type: Article

References (43)

1. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
2. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines
3. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk
4. The insulin-like growth factor binding protein (IGFBP) superfamily
5. Involvement of IGF-II in human cancer
6. Insulin-like growth factor II (IGF-II) and the IGF-II mannose-6-phosphate receptor - The myth continues
7. Metastasizing mammary carcinomas in H19 enhancers IGF 2 transgenic mice
8. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors
9. Insulin-like growth factor-I receptor - Its role in cell proliferation, apoptosis, and tumorigenicity
10. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation
11. M6P/IGF2R is mutated in squamous cell carcinoma of the lung
12. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors
13. Expression of insulin-like growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines
14. Expression of PDGF, IGF-II, BFGF and TGF-β-1 in pulmonary adenocarcinoma
15. Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma
16. Insulin-like growth factor IGF-I and IGF-II protein expression in pulmonary adenocarcinoma - An immunohistochemical study
17. Insulin-like growth factor expression in human cancer cell lines
18. Human tumor bank in Croatia: A possible model for a small bank as a part of the future European tumor bank network
19. Nested polymerase chain reaction for detection of hepatitis C virus RNA in blood derivatives
20. The expression and role of insulin-like growth factor II in malignant hemangiopericytomas
21. Insulin-like growth factor family in malignant hemangiopericytomas: The expression and role of insulin-like growth factor I receptor
22. Characterization of new monoclonal antibodies to human insulin-like growth factor II and their application in Western immunoblot analysis
23. Constitutive insulin-like growth factor-II expression interferes with the enterocyte-like differentiation of CaCo-2 cells
24. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth binding protein-3
25. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
26. Altered expression of the IGF-I receptor in a tamoxifen-resistant human breast cancer cell line
27. Insulin-like growth factor I receptor: Structure, signal transduction and function
28. Insulin-like growth factors and cancer
29. Suramin blockade in insulin-like growth factor I stimulated proliferation of human osteosarcoma cells
30. Interference of the IGF system as a strategy to inhibit breast cancer growth
31. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I
32. Antisense-mediated reduction in insulin-like growth factor I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma
33. IGF-II autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line
34. Insulin-like growth factor II expression in carcinoma in colon cell lines: Implications for autocrine action
35. Autocrine tumour growth regulation by somatomedin C: An in vitro model
36. Growth self-incitement in murine melanoma B16, a phenomenological model
37. Stable amino-acid sequence of the mannose-6-phosphate/ionsulin-like growth-factor-II receptor in ovarian carcinomas with loss of heterozygosity in breast-cancer cell lines
38. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines
39. Insulin-like growth factor-I is an autocrine regulator for the brain metastatic variant of a human non-small cell lung cell line
40. Suramin and serum insulin-like growth factor levels in metastatic cancer patients
41. Monoclonal antibody alpha IR-3 inhibits non-small cell lung cancer growth in vitro and in vivo
42. Production of insulin-like growth factor binding proteins by small cell lung cancer cell lines
43. Molecular pathology of hemangiopericytomas accompanied by severe hypoglycemia: Oncogenes, tumor-suppressor genes and the insulin-like growth factor family